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Dialysis in Liver Failure and Liver Transplantation 
J. McCauley, M. Gaynord, M. Hrinya, and T.E. Starzl 
ACUTE renal failure requiring hemodialysis develops in 10% to 20% of liver transplant recipients. I This 
occurs most often in the setting of multiorgan failure and is 
usually complicated by sepsis. Previous reports have sug-
gested that mortality in these patients may be near 
100%.2-4 Most of these studies have included relatively 
small numbers of patients and were not specifically de-
signed to address the contribution of dialysis to patient 
survival. We have conducted a prospective analysis of all 
potential candidates for liver transplantation and liver 
transplant recipients requiring dialysis support from May 
1988 to June 1989 at the University of Pittsburgh Health 
Center. The purpose of this study is to more clearly define 
the long-term survival of these patients and to determine 
the factors important in predicting outcome. 
PATIENTS AND METHODS 
From May 1988 to June 1989, 141 patients with liver failure or 
liver transplant recipients required hemodialysis at the University 
of Pittsburgh. All transplanted patients received triple therapy 
(cyclosporine [CyA], azathioprine, and prednisone) or CyA and 
prednisone only (double therapy). The immunosuppressant pro-
tocols have been described in detail elsewhere . .l Hemodialysis 
was conducted using cellulose acetate dialysis membranes. When 
patients were hypotensive or otherwise unable to tolerate hemo-
dialysis, continuous venovenous hemofiltration (CVVH) was 
used. 
RESULTS 
Fifty-three (37.6%) patients were potential candidates for 
liver transplantation but were not accepted or died before 
an organ was available. Eighty-eight patients received liver 
transplants; of these, 53 received one, 28 received two, 6 
received three, and 1 patient received four transplants. In 
the transplanted patients, 3 were dialyzed before trans-
plantation, 7 were receiving dialysis at the time of trans-
plantation, and 78 were dialyzed after transplantation. 
Actuarial patient survival was 51% after 18 months in 
the transplanted group. Only three of the liver failure 
patients survived the admission and none for 15 months. 
For both liver failure patients and liver transplant patients, 
gastrointestinal bleeding was the most important determi-
nant of survival. An additional important factor for trans-
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plant patients was number of transplants. Neither ventila-
tor dependence nor the ability to clot hemodialysis filters 
were associated with survival. Most patients in both 
groups were ventilator dependent, on at least one vaso-
pressor, and were relatively hypotensive at some time 
during the admission. Ischemic acute tubular necrosis 
(A TN) was the leading cause of acute renal failure. Hepa-
torenal syndrome was a relatively unusual cause of renal 
failure in both groups and never occurred after transplan-
tation. 
In summary, acute renal failure after liver transplanta-
tion typically occurs in the setting of multiorgan failure and 
is associated with high mortality rates. However, the 
mortality rates previously described in small case series 
probably overestimate the risk of death in these patients. 
The leading cause of renal failure was ischemic A TN and 
not hepatorenal syndrome or nephrotoxic immunosup-
pressants. Patients with liver failure evaluated at our 
center as potential transplant candidates universally died, 
unless a liver transplant could be performed. Uncontrolled 
sepsis or major gastrointestinal bleeding was the proximate 
cause of death in these patients. 
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